AzTrials
AzTrials

COVID-19NCT05080179

Impact of Nudges on Downloads of COVID-19 Exposure Notification Smartphone Apps: A Randomized Trial

A study testing Self-Benefit/Social Norm, Self-Benefit/No Social Norm and Other Benefit/Social Norm in people with COVID-19, run by University of Pennsylvania at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Eligible participants who were active beneficiaries of a large insurer living in Pennsylvania were sent an email encouraging them to download the contact tracing app in Pennsylvania, COVID Alert PA. Participants will be randomly assigned to one of four conditions in a 2 (Self-benefit vs. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
COVID-19
What is being tested?
Self-Benefit/Social Norm, Self-Benefit/No Social Norm and Other Benefit/Social Norm
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16,903 participants
Where
1 siteUnited States
Study dates
11 Dec 2020to 28 Jan 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Eligible participants were active beneficiaries of a large insurer living in Pennsylvania.

Who cannot join

  • Participants who did not subscribe to offers and promotions emails were excluded, as were Medigap beneficiaries.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Independence Blue Cross (IBX)

    Philadelphia, Pennsylvania, 19146

Other trials in United States

About this study

Official title: The Interactive Effect of Social Norm and Self (vs. Others) Benefit Nudges on Downloads of COVID-19 Exposure Notification Smartphone Apps: A Randomized Trial

Eligible participants who were active beneficiaries of a large insurer living in Pennsylvania were sent an email encouraging them to download the contact tracing app in Pennsylvania, COVID Alert PA.

Participants will be randomly assigned to one of four conditions in a 2 (Self-benefit vs. Other-Benefit) x 2 (Social Norms Present vs. Social Norms absent) design.

Read more

All participants received an email that said :

"COVID Alert PA is the official Exposure Notification App from the Pennsylvania Department of Health. Join Penn Medicine in the fight against COVID-19 and download COVID Alert PA today!"

---Investigators manipulated the content here---

"The app uses Bluetooth to sense when one person is in close contact with another person with the app. If someone tests positive for COVID-19, and they decide to upload the information to the health department, people who have the app and who have been in contact with them will be alerted.

If you are interested in downloading the app, please click COVID Alert PA. We appreciate you joining our efforts. Together we can beat COVID-19!"

In the Other-Benefit condition, it said: "It can help you reduce your risk of unknowingly spreading the virus to your friends, family, and larger community."

In the Self-Benefit condition, it said: "It can help you determine where and when to get testing, and how to get care if you need it."

In the Social Norms Present condition, it said: "Over 650,000 Pennsylvanians have already downloaded the app!"

In the Social Norms Absent condition, it said the statement about social norms above.

Participants who do not open the initial email received a follow-up email.

Conditions
COVID-19
Being tested
Self-Benefit/Social Norm, Self-Benefit/No Social Norm, Other Benefit/Social Norm, Other Benefit/No Social Norm
Medical subject headings
COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-Benefit/Social NormBehavioural

    As part of their email, they will read, "It can help you determine where and when to get testing, and how to get care if you need it." and "Over 650,000 Pennsylvanians have already downloaded the app!"

  • Self-Benefit/No Social NormBehavioural

    As part of their email, they will read, "It can help you determine where and when to get testing, and how to get care if you need it." They will not read any information about the number of Pennsylvanians who downloaded the app.

  • Other Benefit/Social NormBehavioural

    As part of their email, they will read, "It can help you reduce your risk of unknowingly spreading the virus to your friends, family, and larger community." and "Over 650,000 Pennsylvanians have already downloaded the app!"

  • Other Benefit/No Social NormBehavioural

    As part of their email, they will read, "It can help you reduce your risk of unknowingly spreading the virus to your friends, family, and larger community." They will not read any information about the number of Pennsylvanians who downloaded the app.

Study groups in NCT05080179
Study groupRoleWhat they receive
Self-Benefit/Social NormExperimentalAs part of their email, they read, "It can help you determine where and when to get testing, and how to get care if you need it." and "Over 650,000 Pennsylvanians have already downloaded the app!"
Receives: Behavioral: Self-Benefit/Social Norm
Self-Benefit/No Social NormExperimentalAs part of their email, they read, "It can help you determine where and when to get testing, and how to get care if you need it." They did not read any information about the number of Pennsylvanians who downloaded the app.
Receives: Behavioral: Self-Benefit/No Social Norm
Other Benefit/Social NormExperimentalAs part of their email, they read, "It can help you reduce your risk of unknowingly spreading the virus to your friends, family, and larger community." and "Over 650,000 Pennsylvanians have already downloaded the app!"
Receives: Behavioral: Other Benefit/Social Norm
Other Benefit/No Social NormExperimentalAs part of their email, they read, "It can help you reduce your risk of unknowingly spreading the virus to your friends, family, and larger community." They did not read any information about the number of Pennsylvanians who downloaded the app.
Receives: Behavioral: Other Benefit/No Social Norm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Click on Link to Download COVID Alert PA App

    The investigators measured choice to click on the link to download the COVID Alert PA app or not, conditional on opening the email. Because participants may not immediately open their e-mail, or may return to the e-mail to click the link, we allowed for a period of approximately 7 weeks or 48 days from date of initial e-mail for completion of outcome measure.

    Measured: 48 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2021
  2. Study start11 Dec 2020
  3. Primary completion28 Jan 2021
  4. Study completion28 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
This is a 2 (Self-Benefit vs. Other-Benefit) x 2 (Social Norm vs. No Social Norm) design. There are thus four conditions total.
Masking
Single blind
Who is masked
Participant
Enrolment
16,903 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05080179
Sponsor's protocol ID
844564
Status last verified
Oct 2022
First submitted
12 Oct 2021
Last updated
28 Aug 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Self-Benefit/Social Norm, Self-Benefit/No Social Norm and Other Benefit/Social Norm in people with COVID-19, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Aug 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Click on Link to Download COVID Alert PA App (time frame: 48 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in